TMJ osteoarthritis is a degenerative disease of the joint, which culminates in the progressive destruction of all soft and hard tissue components of the TMJ. For patients who present in early ...
Please provide your email address to receive an email when new articles are posted on . Performing basic clinical observation on patients with temporomandibular joint arthritis is critical to ...
Temporomandibular joint (TMJ) disorders, or TMD, refers to a group of clinical disorders that affect the TMJ and its associated structures. TMJ osteoarthritis (TMJ OA) is a major subtype of TMDs, ...
Treatment with bone marrow aspirate concentrate (BMAC) may reverse the degenerative effects of osteoarthritis of the temporomandibular joint (TMJ), according to a study published in late September in ...
Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease affecting children. A significant complication of JIA is involvement of the temporomandibular joint (TMJ), where ...
Enlivex Therapeutics (ENLV) announced that the Israeli Ministry of Health authorized the initiation of an investigator-initiated Phase I trial to evaluate the safety, tolerability and initial efficacy ...
Please provide your email address to receive an email when new articles are posted on . Orofacial signs and symptoms are frequent in children with juvenile idiopathic arthritis. Factors that were ...
Glucosamine supplements have benefits for inflammatory disorders. They may slow cartilage destruction, which can reduce pain and swelling. Glucosamine can be used to manage osteoarthritis (OA) and ...
Sympathetic nerves precede sensory nerves and run in parallel with sensory nerves in the subchondral bone of TMJ-OA mice. During the early stage of TMJ-OA, regional sympathetic nerves release ...
The articular disc and mandibular condyle cartilage in the temporomandibular joint (TMJ) endows the joint with its specialized biomechanical functions enabling everyday speaking and chewing. In this ...
Temporomandibular joint (TMJ) osteoarthritis is a degenerative, debilitating and progressive disease, the second most common musculoskeletal condition affecting five to 12% of the population globally ...